6512 ORAL Analysis of possible relationships between tumour biomarkers and clinical benefit from erlotinib in advanced non-small cell lung cancer (NSCLC): data from the prospective MERIT study

✍ Scribed by Reck, M.; Milanowski, J.; Au, S.K.; Yang, P.C.; Akimov, M.; Duymelinck, C.; Gutjahr, T.; McLoughlin, P.; Hillenbach, C.; Felip, E.

• Book ID: 123553576
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 63 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(07)71340-X